Ruxolitinib,INCB057643
Incyte,novartis
['incb057643', 'rux,(-crux),(-trux),(-deruxtecan)', '#mpn', 'ruxolitinib', 'mds', 'rux,(-crux),(-trux)']
congress|#asco23| , presents the preliminary phase i results on bet inhibitor incb057643 alone or combined with ruxolitinib in pts with r/r mf,mds &amp; mds/mpn. it was well tolerated alone (4&amp;8mg,qd) or combined (4mg,qd) and demonstrated efficacy
#mpn 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm